10x Genomics, Inc. TXG Asia-Pacific — Revenue
Other geography segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by 10x Genomics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: 10x Genomics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about 10x Genomics, Inc.'s asia-pacific — revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is 10x Genomics, Inc.'s asia-pacific — revenue?
- 10x Genomics, Inc. (TXG) reported asia-pacific — revenue of $33.89M in Q1 2026.
- How has 10x Genomics, Inc.'s asia-pacific — revenue changed year-over-year?
- 10x Genomics, Inc.'s asia-pacific — revenue increased by 4.5% year-over-year, from $32.42M to $33.89M.
- What is the long-term trend for 10x Genomics, Inc.'s asia-pacific — revenue?
- Over 4 years (2021 to 2025), 10x Genomics, Inc.'s asia-pacific — revenue has grown at a 1.1% compound annual growth rate (CAGR), from $117.01M to $122.33M.
- What does asia-pacific — revenue mean?
- This metric represents the total revenue generated from sales of instruments, consumables, and software solutions within the Asia-Pacific geographic region. It serves as a key indicator of the company's market penetration, adoption of life science technologies, and commercial performance in this specific international territory. Monitoring this figure helps investors assess regional growth trends and the effectiveness of local sales and distribution strategies.